FDA Releases Detailed Reaction Letter for Tasimelteon, a Sleep Aid Made by Vanda Pharmaceuticals.

Published Date: 14 Mar 2024

The FDA has sent a comprehensive response letter to Vanda Pharmaceuticals regarding their tasimelteon, stating that due to identified deficiencies, the medication cannot be approved in its current form.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

2.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

3.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot